The upcoming session targets the operational and strategic hurdles inherent in first-in-human and adaptive trial designs. As study complexity rises, sponsors must move beyond simple speed to integrate biomarker strategies and data analytics that inform long-term program viability. The panel will address how to maintain regulatory confidence and high-quality output while compressing traditional development timelines.
In section Releases
Trialmed Experts to Host Webinar on Early-Phase Clinical Study Design
Clinical development teams face mounting pressure to yield definitive proof-of-concept data while navigating increasingly intricate study protocols. On October 9, 2026, Trialmed’s Craig Boyle and Aishwarya Vyas-Lahar will host a webinar to dissect strategies for balancing rapid execution with the scientific rigor required for early-stage development decisions.
Craig Boyle, Vice President of Medical and Clinical Operations, and Associate Medical Director Aishwarya Vyas-Lahar will provide practical frameworks for managing these operational demands. The discussion aims to equip professionals with methods to mitigate risk early in the development lifecycle, ensuring that data-driven insights support faster progression toward clinical milestones. The live event is scheduled for 11am EDT.
Comments (0)
No comments yet. Be the first!